Sanofi stretches out significant financial commitment in the United States

Sanofi, a prominent French pharmaceutical company, declared on May 14th that they plan to inject a minimum of $20 billion into the US market by 2030. Currently, this region accounts for approximately half of Sanofi's total revenue.